SEARCH   
MEMBER LOGIN    

Athlete's Foot Treatment Manufacturing OTC in the US: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Athlete's Foot Treatment Manufacturing OTC Market Research Report | Life Sciences | OTC Medicines | 2013

IBISWorld’s Athlete's Foot Treatment Manufacturing OTC market research report offers insightful industry analysis and research into the market at the national level. IBISWorld’s in-depth industry market research is presented in a logical and consistent format. The industry report contains key industry statistics, market size, industry trends, and growth and profit forecasts for a 5-year outlook period.

Report Snapshot
Market Share of Companies
Bayer AG Bayer AG market share
Novartis Novartis market share
Sanofi-Aventis U.S. LLC Sanofi-Aventis U.S. LLC market share
Schering-Plough HealthCare Products, Inc. Schering-Plough HealthCare Products, Inc. market share
Industry Statistics & Market Size
Revenue
Add to Cart
 Annual Growth 08-13
Add to Cart
 Annual Growth 13-18
Add to Cart
Profit
Add to Cart
 Employment
Add to Cart
 Businesses
Add to Cart
What is the Athlete's Foot Treatment Manufacturing OTC industry?

This industry manufactures medications to treat common fungal infections of the skin that cause scaling, flaking and itching. This industry includes products that are sold without a prescription... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents
Major products in this industry
Miconazole nitrate-based solutionsTolnaftate-based solutionsTerbinafine-based solutions
 
Examples of brands in this Industry
Lotrimin (Schering-Plough HealthCare Products) Caneston (Bayer)Lamisil (Novartis Consumer Health)Gold Bond (Sanofi Aventis)


View Sample
Quote
Select Clients